Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Number of holders
-
1,458
-
Total 13F shares, excl. options
-
1,027,156,427
-
Shares change
-
-13,854,046
-
Total reported value, excl. options
-
$47,581,322,011
-
Value change
-
-$627,926,143
-
Put/Call ratio
-
78%
-
Number of buys
-
560
-
Number of sells
-
-687
-
Price
-
$46.33
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q1 2015
1,575 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q1 2015.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,458 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,027,156,427 shares
of 1,740,239,592 outstanding shares and own 59.02% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (90,359,272 shares), STATE STREET CORP (65,042,595 shares), BlackRock Institutional Trust Company, N.A. (40,427,968 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (33,362,223 shares), Bank of New York Mellon Corp (30,844,787 shares), NORTHERN TRUST CORP (23,855,856 shares), JENNISON ASSOCIATES LLC (21,571,193 shares), BlackRock Fund Advisors (20,105,898 shares), JPMORGAN CHASE & CO (19,970,566 shares), and PRIMECAP MANAGEMENT CO/CA/ (17,765,299 shares).
This table shows the top 1458 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.